arrow
R

Rishikesan Kamaleswaran

Duke University School of Medicine
H指数:22
被引数:2,357

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical and Metabolomic Panel for Noninvasive Screening of Biopsy-Confirmed MASH in Children and Adolescents

临床与代谢组学联合筛查表:用于活检确诊儿童及青少年MASH的非侵入性检测

2026-08-300
OA
Development of a machine-learning risk stratification tool for vasoactive medication need after two-bolus fluid resuscitation in pediatric suspected sepsis

基于双推注液体复苏后儿科疑似脓毒症患者血管活性药物需求的机器学习风险分层工具的开发

2026-08-290
PRE
Clinical criteria for the definition of refractory septic shock: a joint Delphi consensus from the Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM)

难治性败血症休克定义的临床标准: 重症监护医学会 (SCCM) 和欧洲重症监护医学会 (ESICM) 联合Delphi共识

2026-03-240
PRE
THE INITIAL 50,000 ICU ADMISSIONS WITHIN THE CHORUS BRIDGE2AI MULTIMODAL DATASET

CHORUS BRIDGE2AI 多模态数据集中最初的 50,000 例 ICU 入院病例

2026-03-010
PRE
Clinically distinct metabotypes of pediatric MASLD identified through unsupervised clustering of NASH CRN data

通过无监督聚类NASH CRN数据识别出临床不同的儿科MASLD代谢表型

2026-02-240
OA
Early prediction of antibiotic need and bacteremia risk in non-immunocompromised pediatric emergency patients using machine learning

使用机器学习对非免疫抑制儿科急诊患者进行抗生素需求及早发性菌血症风险的早期预测

2025-12-120
PRE
Neutrophil dysregulation differentiates pediatric septic shock biomarker-based mortality-risk strata: insights from weighted gene co-expression network and transcriptomic analyses

中性粒细胞失调可区分儿科脓毒性休克基于生物标志物的死亡风险分层:加权基因共表达网络和转录组学分析的见解

2025-11-190
OAAI